AMJ Rheumatology 2.1 2025

In this issue

Explore the latest AMJ Rheumatology issue with American College of Rheumatology (ACR) Convergence 2025 highlights including the use of GLP-1 agonists in rheumatic diseases and emerging CAR-T targets in lupus. Abstract reviews examine financial toxicity, immunotherapy-related arthritis, vaccine responses, and social media use, alongside leadership interviews and a striking ANCA case report for everyday clinical practice.